Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

Clinical trial NCT04745299 · COMPLETED

Trial details

NCT number: NCT04745299
Sponsor: Corestemchemon, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-02-24
Primary completion: 2024-10-03
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.